Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.5B |
| 2 |
Apple
AAPL
|
+$1.68B |
| 3 |
Tesla
TSLA
|
+$951M |
| 4 |
Johnson & Johnson
JNJ
|
+$750M |
| 5 |
UnitedHealth
UNH
|
+$703M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$913M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$257M |
| 3 |
NVIDIA
NVDA
|
+$225M |
| 4 |
Vertiv
VRT
|
+$164M |
| 5 |
JPMorgan Chase
JPM
|
+$161M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.48% |
| 2 | Healthcare | 7.36% |
| 3 | Financials | 6.5% |
| 4 | Consumer Discretionary | 5.35% |
| 5 | Industrials | 3.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1176
Independence Realty Trust
IRT
$4.07B
| $10.5M | ﹤0.01% |
621,665
+185,660
| +43% | +$3.14M |
|
1177
PUT
BorgWarner
BWA
$13.9B
| $10.5M | ﹤0.01% |
+295,019
| New | +$10M |
|
1178
News Corp Class A
NWSA
$15.4B
| $10.4M | ﹤0.01% |
572,373
+186,878
| +48% | +$3.25M |
|
1179
Knight Transportation
KNX
$11.4B
| $10.4M | ﹤0.01% |
198,745
+12,478
| +7% | +$645K |
|
1180
PUT
DraftKings
DKNG
$11.9B
| $10.4M | ﹤0.01% |
+912,800
| New | +$12.7M |
|
|
BKI
1181
DELISTED
Black Knight, Inc. Common Stock
BKI
| $10.4M | ﹤0.01% |
168,201
+40,499
| +32% | +$2.46M |
|
1182
CALL
Workday
WDAY
$44.4B
| $10.4M | ﹤0.01% |
+62,000
| New | +$9.67M |
|
1183
NetEase
NTES
$84.7B
| $10.4M | ﹤0.01% |
142,620
-80,282
| -36% | -$5.46M |
|
|
MRTX
1184
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $10.3M | ﹤0.01% |
228,425
+101,331
| +80% | +$6.56M |
|
1185
Polaris
PII
$4.07B
| $10.3M | ﹤0.01% |
102,279
+70,492
| +222% | +$7.34M |
|
|
1186
CALL
BorgWarner
BWA
$13.9B
| $10.3M | ﹤0.01% |
+291,384
| New | +$9.91M |
|
1187
iShares Russell 2000 Value ETF
IWN
$14.6B
| $10.3M | ﹤0.01% |
74,369
-17,580
| -19% | -$2.48M |
|
1188
CALL
ArcelorMittal
MT
$55.3B
| $10.3M | ﹤0.01% |
+392,800
| New | +$9.64M |
|
|
X
1189
DELISTED
US Steel
X
| $10.3M | ﹤0.01% |
410,832
-1,357,688
| -77% | -$31.3M |
|
1190
PUT
Ovintiv
OVV
$16.4B
| $10.3M | ﹤0.01% |
+202,700
| New | +$10.6M |
|
1191
PUT
Intuitive Surgical
ISRG
$134B
| $10.3M | ﹤0.01% |
+38,700
| New | +$9.44M |
|
1192
CALL
Diamondback Energy
FANG
$52.7B
| $10.3M | ﹤0.01% |
+75,000
| New | +$11M |
|
1193
CALL
Applovin
APP
$116B
| $10.2M | ﹤0.01% |
+973,000
| New | +$14.3M |
|
1194
Portland General Electric
POR
$5.77B
| $10.2M | ﹤0.01% |
208,167
+66,597
| +47% | +$3.09M |
|
1195
Sabra Healthcare REIT
SBRA
$5.37B
| $10.2M | ﹤0.01% |
816,870
+36,711
| +5% | +$468K |
|
|
JJN
1196
DELISTED
iPath Series B Bloomberg Nickel Subindex Total ReturnSM ETN
JJN
| $10.1M | ﹤0.01% |
255,000
+170,000
| +200% | +$5.77M |
|
1197
CALL
Southwest Airlines
LUV
$23B
| $10.1M | ﹤0.01% |
+300,000
| New | +$10.8M |
|
|
1198
Applovin
APP
$116B
| $10.1M | ﹤0.01% |
954,733
+709,634
| +290% | +$10.4M |
|
|
ITCI
1199
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $10M | ﹤0.01% |
189,529
+124,090
| +190% | +$6.22M |
|
1200
Coty
COTY
$2.48B
| $10M | ﹤0.01% |
1,168,454
-381,022
| -25% | -$2.8M |
|
Similar funds
Barclays's Q4 2022 Portfolio in Review
As of Q4 2022, Barclays held 5,646 positions worth $223B, up 144% from $91.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $128B of net new capital in Q4 2022, opening 797 new positions and adding to 2,634 existing holdings. Its largest new stake was Seadrill: 1,546,558 shares worth $50.5M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $257M trimmed.
- Barclays's largest Q4 2022 buy was Seadrill: 1,546,558 shares worth $50.5M.
- Barclays added most to Microsoft in Q4 2022, an estimated $2.5B increase.
- Barclays's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $257M.
- Barclays fully exited Citrix Systems Inc in Q4 2022, selling an estimated $913M.
- Barclays's ten largest holdings make up 41% of its $223B portfolio in Q4 2022.
- Barclays opened 797 new positions and closed 385 in Q4 2022.
- Barclays's portfolio value rose 144% quarter-over-quarter to $223B.
Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.